Opthea Financial Statements From 2010 to 2025
| OPTDelisted Stock | USD 3.41 0.07 2.01% |
Check Opthea financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opthea's main balance sheet or income statement drivers, such as , as well as many indicators such as . Opthea financial statements analysis is a perfect complement when working with Opthea Valuation or Volatility modules.
Opthea |
Opthea Company Return On Equity Analysis
Opthea's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Opthea Return On Equity | -33.83 |
Most of Opthea's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opthea is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Opthea has a Return On Equity of -33.8308. This is 41.14% higher than that of the Biotechnology sector and 7.21% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Opthea Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Opthea's current stock value. Our valuation model uses many indicators to compare Opthea value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Opthea competition to find correlations between indicators driving Opthea's intrinsic value. More Info.Opthea is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Opthea by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Opthea Financial Statements
Opthea shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Opthea investors may analyze each financial statement separately, they are all interrelated. The changes in Opthea's assets and liabilities, for example, are also reflected in the revenues and expenses on on Opthea's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Opthea Stock
If you are still planning to invest in Opthea check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opthea's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |